GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » CERo Therapeutics Holdings Inc (NAS:CERO) » Definitions » Stock Based Compensation

CERo Therapeutics Holdings (CERo Therapeutics Holdings) Stock Based Compensation : $0.38 Mil (TTM As of Dec. 2022)


View and export this data going back to 2024. Start your Free Trial

What is CERo Therapeutics Holdings Stock Based Compensation?

CERo Therapeutics Holdings's Stock Based Compensation for the six months ended in Dec. 2022 was $0.38 Mil. Its Stock Based Compensation for the trailing twelve months (TTM) ended in Dec. 2022 was $0.38 Mil.


CERo Therapeutics Holdings Stock Based Compensation Historical Data

The historical data trend for CERo Therapeutics Holdings's Stock Based Compensation can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

CERo Therapeutics Holdings Stock Based Compensation Chart

CERo Therapeutics Holdings Annual Data
Trend Dec21 Dec22
Stock Based Compensation
0.29 0.38

CERo Therapeutics Holdings Semi-Annual Data
Dec21 Dec22
Stock Based Compensation 0.29 0.38

CERo Therapeutics Holdings Stock Based Compensation Calculation

Stock Based Compensation is a way corporations use stock options to reward employees. It provides executives and employees the opportunity to share in the growth of the company and, if structured properly, can align their interests with the interests of the company's shareholders and investors, without burning the company's cash on hand.

For stock reported annually, GuruFocus uses latest annual data as the TTM data. Stock Based Compensation for the trailing twelve months (TTM) ended in Dec. 2022 was $0.38 Mil.


CERo Therapeutics Holdings Stock Based Compensation Related Terms

Thank you for viewing the detailed overview of CERo Therapeutics Holdings's Stock Based Compensation provided by GuruFocus.com. Please click on the following links to see related term pages.


CERo Therapeutics Holdings (CERo Therapeutics Holdings) Business Description

Comparable Companies
Traded in Other Exchanges
N/A
Address
201 Haskings Way, Suite 230, San Francisco, CA, USA, 94080
CERo Therapeutics Holdings Inc is an innovative immunotherapy company advancing the development of next-generation engineered T-cell therapeutics for the treatment of cancer. Its proprietary approach to T cell engineering, which enables it to integrate certain desirable characteristics of both innate and adaptive immunity into a single therapeutic construct, is designed to engage the body's full immune repertoire to achieve optimized cancer therapy.

CERo Therapeutics Holdings (CERo Therapeutics Holdings) Headlines